+
Site Tour

Cardiac imaging in AS - bioprosthetic valve dysfunction M. Saad

2nd Annual International TAVI Summit

FIND OUT MORE ON TAVI SUMMIT 2024:

Watch on Demand videos

Related Videos

TAVI Summit - TAVR in bicuspid

TAVI Summit - Live case from Berlin

TAVI Summit - What is coming next

TAVI Summit - Live case from Berlin

TAVI Summit - TAVR in bicuspid

EACVI Summit 2023: Congress symposium

TAVI 2023: Calcified valve

PremiClose 2024: Beside PDA closure

TAVI Summit - Drive TAVI to the next level

EuroPCR 2023: Vascular access

TAVI 2023: Younger patients

TAVI Summit - Cardiac imaging and morphology

TRENDING TOPICS

AV Valves Summit 2024 | Opening of Day 2

AV Valves Summit 2024 | Opening of Day 2

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

AV Valves Summit 2024 | Closing of Day 1

AV Valves Summit 2024 | Closing of Day 1

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

Case Parade | Tricuspid focus

Case Parade | Tricuspid focus

M. Sitges, R. Estevez, V. Ninios, E. L. Heng, X. Freixa, W. Wojakowski, C. Besler

CONNEXT


TV
RELATED RESOURCES

ESC 2022: TEER Tutorial

Narcisa's testimonial

PCRLV 2021: Transcatheter mitral valve replacement

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

CONNEXT


HUB
RELATED RESOURCES

Amplatzer™ Valvular Plug III – HCP

Amplatzer™ Valvular Plug III – Patients

ESC 2021: HF & VHD Guidelines

Tendyne™: 6-Year Outcomes

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline